Literature DB >> 27784694

Deficiency of mPGES-1 exacerbates renal fibrosis and inflammation in mice with unilateral ureteral obstruction.

Renfei Luo1, Yutaka Kakizoe2, Feifei Wang1, Xiang Fan3, Shan Hu1, Tianxin Yang1,2, Weidong Wang1, Chunling Li4.   

Abstract

Microsomal prostaglandin E2 synthase-1 (mPGES-1), an inducible enzyme that converts prostaglandin H2 to prostaglandin E2 (PGE2), plays an important role in a variety of inflammatory diseases. We investigated the contribution of mPGES-1 to renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) for 7 days using wild-type (WT) and mPGES-1 knockout (KO) mice. UUO induced increased mRNA and protein expression of mPGES-1 and cyclooxygenase-2 in WT mice. UUO was associated with increased renal PGE2 content and upregulated PGE2 receptor (EP) 4 expression in obstructed kidneys of both WT and mPGES-1 KO mice; EP4 expression levels were higher in KO mice with UUO than those in WT mice. Protein expression of NLRP3 inflammasome components ASC and interleukin-1β was significantly increased in obstructed kidneys of KO mice compared with that in WT mice. mRNA expression levels of fibronectin, collagen III, and transforming growth factor-β1 (TGF-β1) were significantly higher in obstructed kidneys of KO mice than that in WT mice. In KO mice, protein expression of fibronectin and collagen III was markedly increased in obstructed kidneys compared with WT mice, which was associated with increased phosphorylation of protein kinase B (AKT). EP4 agonist CAY10598 attenuated increased expression of collagen I and fibronectin induced by TGF-β1 in inner medullary collecting duct 3 cells. Moreover, CAY10598 prevented the activation of NLRP3 inflammasomes induced by angiotensin II in human proximal tubule cells (HK2). In conclusion, these findings suggested that mPGES-1 exerts a potentially protective effect against renal fibrosis and inflammation induced by UUO in mice.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  AKT; fibrosis; inflammasomes; prostaglandin

Mesh:

Substances:

Year:  2016        PMID: 27784694      PMCID: PMC6109695          DOI: 10.1152/ajprenal.00231.2016

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  46 in total

1.  Expression of the calcium-binding protein S100A4 is markedly up-regulated by osmotic stress and is involved in the renal osmoadaptive response.

Authors:  Christopher J Rivard; Lewis M Brown; Nestor E Almeida; Arvid B Maunsbach; Kaarina Pihakaski-Maunsbach; Ana Andres-Hernando; Juan M Capasso; Tomas Berl
Journal:  J Biol Chem       Date:  2007-01-02       Impact factor: 5.157

2.  Mesenchymal transition in kidney collecting duct epithelial cells.

Authors:  Larissa Ivanova; Michael J Butt; Douglas G Matsell
Journal:  Am J Physiol Renal Physiol       Date:  2008-03-05

Review 3.  Prostaglandin E2 modulation of blood pressure homeostasis: studies in rodent models.

Authors:  Christina E Swan; Richard M Breyer
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-07-27       Impact factor: 3.072

Review 4.  The cardinal role of the phospholipase A(2)/cyclooxygenase-2/prostaglandin E synthase/prostaglandin E(2) (PCPP) axis in inflammostasis.

Authors:  A D Mancini; J A Di Battista
Journal:  Inflamm Res       Date:  2011-10-01       Impact factor: 4.575

5.  COX-2 inhibition prevents downregulation of key renal water and sodium transport proteins in response to bilateral ureteral obstruction.

Authors:  Rikke Nørregaard; Boye L Jensen; Chunling Li; Weidong Wang; Mark A Knepper; Søren Nielsen; Jørgen Frøkiaer
Journal:  Am J Physiol Renal Physiol       Date:  2005-04-19

6.  Role of cyclooxygenase-2 in the development of interstitial fibrosis in kidneys following unilateral ureteral obstruction in mice.

Authors:  Mariko Kamata; Kanako Hosono; Tomoe Fujita; Kouju Kamata; Masataka Majima
Journal:  Biomed Pharmacother       Date:  2015-01-15       Impact factor: 6.529

7.  Characterization and distribution of interstitial cell types in the renal cortex of rats.

Authors:  B Kaissling; M Le Hir
Journal:  Kidney Int       Date:  1994-03       Impact factor: 10.612

Review 8.  Chronic kidney disease: targeting prostaglandin E2 receptors.

Authors:  Rania Nasrallah; Ramzi Hassouneh; Richard L Hébert
Journal:  Am J Physiol Renal Physiol       Date:  2014-06-25

9.  Role of microsomal prostaglandin E synthase 1 in the kidney.

Authors:  Helene Francois; Carie Facemire; Anil Kumar; Laurent Audoly; Beverly Koller; Thomas Coffman
Journal:  J Am Soc Nephrol       Date:  2007-04-18       Impact factor: 10.121

10.  Key enzymes for renal prostaglandin synthesis: site-specific expression in rodent kidney (rat, mouse).

Authors:  Valentina Câmpean; Franziska Theilig; Alex Paliege; Matthew Breyer; Sebastian Bachmann
Journal:  Am J Physiol Renal Physiol       Date:  2003-03-25
View more
  7 in total

1.  Enhanced mPGES-1 Contributes to PD-Related Peritoneal Fibrosis via Activation of the NLRP3 Inflammasome.

Authors:  Qimei Luo; Qinghua Hu; Qingkun Zheng; Lewei Gong; Lijuan Su; Baojun Ren; Yongle Ju; Zhanjun Jia; Xianrui Dou
Journal:  Front Med (Lausanne)       Date:  2021-05-18

2.  Mechanosensitive Piezo1 channels mediate renal fibrosis.

Authors:  Xiaoduo Zhao; Yonglun Kong; Baien Liang; Jinhai Xu; Yu Lin; Nan Zhou; Jing Li; Bin Jiang; Jianding Cheng; Chunling Li; Weidong Wang
Journal:  JCI Insight       Date:  2022-04-08

3.  Increased COX-2 after ureter obstruction attenuates fibrosis and is associated with EP2 receptor upregulation in mouse and human kidney.

Authors:  Signe S Tofteng; Line Nilsson; Amalie K Mogensen; Rikke Nørregaard; Rolf Nüsing; Mikhail Diatchikhine; Lars Lund; Claus Bistrup; Boye L Jensen; Kirsten Madsen
Journal:  Acta Physiol (Oxf)       Date:  2022-05-20       Impact factor: 7.523

Review 4.  The Roles of Various Prostaglandins in Fibrosis: A Review.

Authors:  Ke Li; Jing Zhao; Mingxuan Wang; Lingzhi Niu; Yuanping Wang; Yanxia Li; Yajuan Zheng
Journal:  Biomolecules       Date:  2021-05-24

Review 5.  Prostaglandins in the pathogenesis of kidney diseases.

Authors:  Yuanyuan Li; Weiwei Xia; Fei Zhao; Zhaoying Wen; Aihua Zhang; Songming Huang; Zhanjun Jia; Yue Zhang
Journal:  Oncotarget       Date:  2018-05-29

6.  EP4 activation ameliorates liver ischemia/reperfusion injury via ERK1/2‑GSK3β‑dependent MPTP inhibition.

Authors:  Lin-Lin Cai; Hai-Tao Xu; Qi-Long Wang; Ya-Qing Zhang; Wei Chen; Dong-Yu Zheng; Fang Liu; Hong-Bin Yuan; Yong-Hua Li; Hai-Long Fu
Journal:  Int J Mol Med       Date:  2020-03-17       Impact factor: 4.101

7.  Prostaglandin E2 receptors as therapeutic targets in renal fibrosis.

Authors:  Henricus A M Mutsaers; Rikke Nørregaard
Journal:  Kidney Res Clin Pract       Date:  2022-01-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.